Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells
Chie Nishioka(Kōchi University), Akihito Yokoyama(Kōchi University)
Cited by 86
Related Papers
Downregulation of miR‐217 correlates with resistance of ph<sup>+</sup> leukemia cells to <scp>ABL</scp> tyrosine kinase inhibitors
|Cancer Science|2013|60
Expression of p‐JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemia
|International Journal of Cancer|2011|47
Analysis of Aurora B kinase in non-Hodgkin lymphoma
|Laboratory Investigation|2009|39
Bcr‐Abl activates AURKA and AURKB in chronic myeloid leukemia cells <i>via</i> AKT signaling
|International Journal of Cancer|2013|39
AZ960, a Novel Jak2 Inhibitor, Induces Growth Arrest and Apoptosis in Adult T-Cell Leukemia Cells
|Molecular Cancer Therapeutics|2010|29